Xeris Biopharma Holdings, Inc. (XERS) Balance Sheet Annual - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-03-06 2024-03-06 2023-03-08 2022-03-11 2022-03-11 2020-12-31 2019-03-06 2017-12-31 2016-12-31
Total Current Assets 167.7 156.3 186.8 142.6 152.2 87.48 117.9 44.05 33.17
Cash and Short Term Investments 71.62 72.45 122 102.4 133.8 75.55 112.6 42.05 32.27
Cash & Equivalents 71.62 67.45 122 67.27 37.6 19.52 45.72 42.05 32.27
Short Term Investments 0 5 0 35.16 96.19 56.03 66.92 0 0
Receivables 40.41 39.2 30.83 17.46 6.88 4.69 2.87 1.2 0.101
Inventory 48.17 38.84 24.73 18.12 8.35 2.18 0 0 0
Other Current Assets 7.45 5.78 9.29 4.59 3.2 5.07 2.4 0.809 0.804
Total Assets 323.1 322.6 344.5 304.4 159.2 109 120 45 33.53
Total Non-Current Assets 155.4 166.3 157.7 161.8 6.94 21.5 2.13 0.945 0.359
Property, Plant and Equipment 28.21 29.18 9.51 6.63 6.71 7.85 2.03 0.788 0.312
Goodwill and Intangible Assets 121.8 132.6 143.5 154.3 0 0 0 0 0
Goodwill 22.86 22.86 22.86 22.86 0 0 0 0 0
Intangible Assets 98.92 109.8 120.6 131.4 0 0 0 0 0
Long Term Investments 4.12 0 0 0 0 13.23 0 0 0
Deferred Tax Assets 6.09 0 0 0 0 0 0 0 0
Other Long Term Assets -4.81 4.54 4.73 0.829 0.232 0.42 0.095 0.157 0.047
Total Current Liabilities 100.4 95.19 73.62 79.04 28.21 27.34 10.17 4.86 2.53
Accounts Payable 2.29 11.56 4.61 8.92 3.12 5.6 0.866 1.98 1.31
Notes Payable/Short Term Debt 21.18 3.5 1.58 0 0 0 0 0 0
Tax Payables 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0.232 0.234 0.263
Other Current Liabilities 76.97 80.13 67.44 70.12 25.09 21.73 9.07 2.65 0.949
Total Liabilities 352.7 329.4 299.3 209.1 125.4 94.55 44.62 102.8 65.47
Total Non-Current Liabilities 252.2 234.2 225.7 130.1 97.18 67.21 34.45 97.97 62.94
Total Long Term Debt 250.3 225.7 196.5 88.07 87.02 58.3 31.89 0 0
Deferred Tax Liabilities Non-Current 0 2.27 3.52 4.94 0 0 0 0 0
Deferred Revenue Non-Current 0 0 0 0 0 0 0 0 0
Capital Lease Obligations 39.34 38.26 10.98 0 0 0 0 0 0
Other Long Term Liabilities -37.37 -32.03 14.74 37.08 10.16 8.91 2.56 97.97 62.94
Total Equity -29.61 -6.78 45.19 95.23 33.76 14.44 75.41 -57.83 -31.93
Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity -29.61 -6.78 45.19 95.23 33.76 14.44 75.41 -57.83 -31.93
Retained Earnings -671.9 -617 -554.8 -460.1 -337.4 -246.2 -120.7 -60.59 -34.03
Accumulated Other Earnings -0.025 -0.025 -0.023 -0.031 0.006 0.043 -0.052 -0.44 -0.268
Common Stock 0.015 0.014 0.014 0.013 0.006 0.003 0.002 0.001 0.001
Preferred Stock 0 0 0 0 0 0 0 97.88 62.9
Additional Paid in Capital 642.3 610.3 600 555.4 371.1 260.6 196.1 -97.44 -62.63
Total Liabilities & Total Equity 323.1 322.6 344.5 304.4 159.2 109 120 45 33.53
Total Liabilities & Shareholders' Equity 323.1 322.6 344.5 304.4 159.2 109 120 45 33.53
Total Investments 4.12 5 0 35.16 96.19 69.26 66.92 0 0
Total Debt 271.4 229.2 198.1 88.07 87.02 58.3 31.89 0 0
Net Debt 199.8 161.7 76.09 20.8 49.42 38.79 -13.83 -42.05 -32.27
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program